Patrick S Stayton

USPTO Granted Patents = 37 (Patent Applications = 18)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 4.0

ph-index = 14

Forward Citations = 849(Granted Patents)

Company Filing History:

36 out of 2,099

University of Washington

University of Massachusetts

patents

4. 2 out of 7

Genevant Sciences Gmbh

patents

5. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12329773 - Oxygen reactive polymers for treatment of traumatic brain injury (2025-06-17),

2. 11707483 - Micellic assemblies (2023-07-25),

3. 11065272 - Oxygen reactive polymers for treatment of traumatic brain injury (2021-07-20),

4. 10709791 - Stabilized polymeric carriers for therapeutic agent delivery (2020-07-14),

5. 10420790 - Micellic assemblies (2019-09-24),

6. 10066043 - ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization (2018-09-04),

7. 9862792 - Diblock copolymers and polynucleotide complexes thereof for delivery into cells (2018-01-09),

8. 9750814 - Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins (2017-09-05),

9. 9662403 - Micellic assemblies (2017-05-30),

10. 9593169 - Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization (2017-03-14),

11. 9476063 - Diblock copolymers and polynucleotide complexes thereof for delivery into cells (2016-10-25),

12. 9464300 - Multiblock copolymers (2016-10-11),

13. 9429570 - Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates (2016-08-30),

14. 9415113 - Targeting monomers and polymers having targeting blocks (2016-08-16),

15. 9339558 - Micellic assemblies (2016-05-17),

Title: Patrick S Stayton: A Visionary in Biotechnology Innovation

Introduction:

Patrick S Stayton, based in Seattle, WA (US), is a renowned inventor whose relentless pursuit of innovation and passion for improving healthcare have established him as a visionary in the field of biotechnology. With 36 patents to his name, Stayton's work continues to inspire the next generation of inventors and researchers in the medical field.

Latest Patents:

Stayton's latest patents include groundbreaking inventions such as Micellar Assemblies and Oxygen Reactive Polymers for the treatment of traumatic brain injury. The Micellar Assemblies consist of pH-sensitive particles comprising a plurality of copolymers. On the other hand, the Oxygen Reactive Polymers utilize multi-functional structures for ROS scavenging and theranostic applications in treating traumatic brain injury.

Career Highlights:

Having worked at the University of Washington and Phaserx, Inc., Stayton has made significant contributions to the field of biotechnology. His innovative approaches to healthcare solutions have led to the development of novel technologies with far-reaching implications.

Collaborations:

Throughout his career, Stayton has collaborated with industry experts such as Allan Sachs Hoffman and Paul Hickok Johnson. These partnerships have been instrumental in bringing his inventions to life and advancing the field of biotechnology.

Conclusion:

In conclusion, Patrick S Stayton's dedication to innovation and his impact on healthcare technologies underscore his position as a visionary inventor in the realm of biotechnology. His work serves as a beacon of inspiration for aspiring inventors and researchers looking to push the boundaries of what is possible in the medical field.

This text is generated by artificial intelligence and may not be accurate.